表紙:世界のゲノム編集市場規模調査:アプリケーション別、最終用途別(バイオ&製薬企業、学術・政府調査機関、受託調査機関)および地方予測(2021年~2027年)
市場調査レポート
商品コード
1016931

世界のゲノム編集市場規模調査:アプリケーション別、最終用途別(バイオ&製薬企業、学術・政府調査機関、受託調査機関)および地方予測(2021年~2027年)

Global Genome editing Market Size study, by Application, End use (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Contract Research Organizations ) and Regional Forecasts 2021-2027

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=135.61円
世界のゲノム編集市場規模調査:アプリケーション別、最終用途別(バイオ&製薬企業、学術・政府調査機関、受託調査機関)および地方予測(2021年~2027年)
出版日: 2021年06月23日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のゲノム編集の市場規模は、2020年に約37億米ドルと評価され、2021年から2027年の予測期間にわたって22.9%を超える健全な成長率で成長すると予想されています。

ゲノム編集は、科学者がDNAに変更を加えて、目の色や病気のリスクなどの身体的特徴を変化させることを可能にする技術です。CRISPRゲノム編集技術の採用の増加とともに、合成遺伝子の需要の高まりが市場の成長を後押ししています。ただし、臨床翻訳に関する課題は、2021年から2027年の予測期間にわたって市場の成長を妨げます。また、遺伝子編集技術の技術進歩は、予測期間中に市場の成長を増加させる可能性があります。

当レポートでは、世界のゲノム編集市場を調査し、市場の概要、市場の成長要因および阻害要因の分析、市場機会、タイプ別、地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界のゲノム編集市場の定義と範囲

第3章 世界のゲノム編集市場力学

  • ゲノム編集市場の影響分析(2019年~2027年)

第4章 世界のゲノム編集市場の産業分析

  • ポーターの5フォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論

第5章 アプリケーション別の世界のゲノム編集市場

  • 市場スナップショット
  • アプリケーション別、パフォーマンス別の世界のゲノム編集市場-潜在的な分析
  • アプリケーション別の世界のゲノム編集市場の推定と予測 2018年~2027年(10億米ドル)
  • ゲノム編集市場のサブセグメント分析
    • 遺伝子工学
    • 臨床応用

第6章 最終用途別の世界のゲノム編集市場

  • 市場スナップショット
  • 最終用途別、パフォーマンス別の世界のゲノム編集市場-潜在的な分析
  • 最終用途別の世界のゲノム編集市場の推定と予測 2018年~2027年(10億米ドル)
  • ゲノム編集市場のサブセグメント分析
    • バイオテクノロジーおよび製薬企業
    • 学術・政府調査機関
    • 委託調査機関(CRO)

第7章 世界のゲノム編集市場の地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第8章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Precision Biosciences
    • Merck KGaA
    • Cibus
    • Recombinetics, Inc
    • Sangamo
    • Editas Medicine
    • Crispr therapeutics
    • Intellia Therapeutics, Inc.
    • Caribou Biosciences, Inc
    • Cellectis

第9章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Genome editing market, report scope
  • TABLE 2. Global Genome editing market estimates & forecasts by Region 2018-2027 (USD Billion)
  • TABLE 3. Global Genome editing market estimates & forecasts by Application 2018-2027 (USD Billion)
  • TABLE 4. Global Genome editing market estimates & forecasts by End use 2018-2027 (USD Billion)
  • TABLE 5. Global Genome editing market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 6. Global Genome editing market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 7. Global Genome editing market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 8. Global Genome editing market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 9. Global Genome editing market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 10. Global Genome editing market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 11. Global Genome editing market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 12. Global Genome editing market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 13. Global Genome editing market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 14. Global Genome editing market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 15. U.S. Genome editing market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 16. U.S. Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 17. U.S. Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 18. Canada Genome editing market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 19. Canada Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 20. Canada Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 21. UK Genome editing market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 22. UK Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 23. UK Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 24. Germany Genome editing market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 25. Germany Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 26. Germany Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 27. RoE Genome editing market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 28. RoE Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 29. RoE Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 30. China Genome editing market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 31. China Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 32. China Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 33. India Genome editing market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 34. India Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 35. India Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 36. Japan Genome editing market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 37. Japan Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 38. Japan Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 39. RoAPAC Genome editing market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 40. RoAPAC Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 41. RoAPAC Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 42. Brazil Genome editing market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 43. Brazil Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 44. Brazil Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 45. Mexico Genome editing market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 46. Mexico Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 47. Mexico Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 48. RoLA Genome editing market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 49. RoLA Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 50. RoLA Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 51. Row Genome editing market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 52. Row Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 53. Row Genome editing market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 54. List of secondary sources, used in the study of global Genome editing market
  • TABLE 55. List of primary sources, used in the study of global Genome editing market
  • TABLE 56. Years considered for the study
  • TABLE 57. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Genome editing market, research methodology
  • FIG 2. Global Genome editing market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Genome editing market, key trends 2020
  • FIG 5. Global Genome editing market, growth prospects 2021-2027
  • FIG 6. Global Genome editing market, porters 5 force model
  • FIG 7. Global Genome editing market, pest analysis
  • FIG 8. Global Genome editing market, value chain analysis
  • FIG 9. Global Genome editing market by segment, 2018 & 2027 (USD Billion)
  • FIG 10. Global Genome editing market by segment, 2018 & 2027 (USD Billion)
  • FIG 11. Global Genome editing market by segment, 2018 & 2027 (USD Billion)
  • FIG 12. Global Genome editing market by segment, 2018 & 2027 (USD Billion)
  • FIG 13. Global Genome editing market by segment, 2018 & 2027 (USD Billion)
  • FIG 14. Global Genome editing market, regional snapshot 2018 & 2027
  • FIG 15. North America Genome editing market 2018 & 2027 (USD Billion)
  • FIG 16. Europe Genome editing market 2018 & 2027 (USD Billion)
  • FIG 17. Asia pacific Genome editing market 2018 & 2027 (USD Billion)
  • FIG 18. Latin America Genome editing market 2018 & 2027 (USD Billion)
  • FIG 19. Global Genome editing market, company market share analysis (2020)
目次

Global Genome editing Market is valued approximately USD 3.7 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 22.9 % over the forecast period 2021-2027. Genome editing is a technology which enable scientists to make changes to DNA, leading to changes in physical traits such as eye color, and disease risk. Rising synthetic gene demand along with growing adoption of CRISPR genome editing technology is driving the market growth. For Instance: as per the Department of biotechnology in India 24 Industry Projects worth Rs. 12.62 Crore and 4 Extramural Projects (DBT/DST) worth Rs. 6.24 Crore in biotechnology field. However, challenges with respect to clinical translation impedes the growth of the market over the forecast period of 2021-2027. Also, technological advancements in gene editing technologies, are likely to increase the market growth during the forecast period.

Global Genome editing Market is segmented on the basis of geographical reason as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is deemed as leader of market and witnessed robust growth owing to growing investment in biotechnology and technological advancement in gene editing technologies. Whereas, Asia-Pacific is coming up as one of the promising regions as huge market growth is observed due to factors such as rising population, growing health infrastructure, advancement in biotechnology in the region.

Major market player included in this report are:

Precision Biosciences

Merck KGaA

Cibus

Recombinetics, Inc

Sangamo

Editas Medicine

Crispr therapeutics

Intellia Therapeutics, Inc.

Caribou Biosciences, Inc

Cellectis

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application:

Genetic Engineering

Clinical Applications

By End use:

Biotechnology & Pharmaceutical Companies

Academic & Government Research Institutes

Contract Research Organizations (CROs)

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019

Base year - 2020

Forecast period - 2021 to 2027

Target Audience of the Global Genome editing Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
    • 1.2.1. Genome editing Market, by region, 2019-2027 (USD Billion)
    • 1.2.2. Genome editing Market, by Application, 2019-2027 (USD Billion)
    • 1.2.3. Genome editing Market, by End use, 2019-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Genome editing Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Genome editing Market Dynamics

  • 3.1. Genome editing Market Impact Analysis (2019-2027)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Success in pre-clinical models drives demands for genome editing therapeutics
      • 3.1.1.2. Rising adoption in biotechnology
    • 3.1.2. Market Challenges
      • 3.1.2.1. Challenges with respect to clinical translation
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Technological advancements in gene editing technologies

Chapter 4. Global Genome editing Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Genome editing Market, by Application

  • 5.1. Market Snapshot
  • 5.2. Global Genome editing Market by Application, Performance - Potential Analysis
  • 5.3. Global Genome editing Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
  • 5.4. Genome editing Market, Sub Segment Analysis
    • 5.4.1. Genetic Engineering
    • 5.4.2. Clinical Applications

Chapter 6. Global Genome editing Market, by End use

  • 6.1. Market Snapshot
  • 6.2. Global Genome editing Market by End use, Performance - Potential Analysis
  • 6.3. Global Genome editing Market Estimates & Forecasts by End use 2018-2027 (USD Billion)
  • 6.4. Genome editing Market, Sub Segment Analysis
    • 6.4.1. Biotechnology & Pharmaceutical Companies
    • 6.4.2. Academic & Government Research Institutes
    • 6.4.3. Contract Research Organizations (CROs)

Chapter 7. Global Genome editing Market, Regional Analysis

  • 7.1. Genome editing Market, Regional Market Snapshot
  • 7.2. North America Genome editing Market
    • 7.2.1. U.S. Genome editing Market
      • 7.2.1.1. Application breakdown estimates & forecasts, 2018-2027
      • 7.2.1.2. End use breakdown estimates & forecasts, 2018-2027
    • 7.2.2. Canada Genome editing Market
  • 7.3. Europe Genome editing Market Snapshot
    • 7.3.1. U.K. Genome editing Market
    • 7.3.2. Germany Genome editing Market
    • 7.3.3. France Genome editing Market
    • 7.3.4. Spain Genome editing Market
    • 7.3.5. Italy Genome editing Market
    • 7.3.6. Rest of Europe Genome editing Market
  • 7.4. Asia-Pacific Genome editing Market Snapshot
    • 7.4.1. China Genome editing Market
    • 7.4.2. India Genome editing Market
    • 7.4.3. Japan Genome editing Market
    • 7.4.4. Australia Genome editing Market
    • 7.4.5. South Korea Genome editing Market
    • 7.4.6. Rest of Asia Pacific Genome editing Market
  • 7.5. Latin America Genome editing Market Snapshot
    • 7.5.1. Brazil Genome editing Market
    • 7.5.2. Mexico Genome editing Market
  • 7.6. Rest of The World Genome editing Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Precision Biosciences
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Merck KGaA
    • 8.2.3. Cibus
    • 8.2.4. Recombinetics, Inc
    • 8.2.5. Sangamo
    • 8.2.6. Editas Medicine
    • 8.2.7. Crispr therapeutics
    • 8.2.8. Intellia Therapeutics, Inc.
    • 8.2.9. Caribou Biosciences, Inc
    • 8.2.10. Cellectis

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption